
Ypsomed doubles profits and confirms outlook
Ad hoc announcement pursuant to Art. 53 LR

Ypsomed leaves DiaExpert in new hands and focuses on own products
Ad hoc announcement pursuant to Art. 53 LR

Ypsomed introduces new autoinjector for volumes up to 5.5 ml
Press Releases Ypsomed Group

Ypsomed partners with leading digital therapeutics innovator Sidekick Health to improve therapy outcomes
Press Releases Ypsomed Group

mylife YpsoPump bolus delivery via smartphone
Press Releases Ypsomed Group